| MicroRNAs in health and disease--basic science and clinical applications. A Osman Clinical laboratory 58 (5-6), 393-402, 2012 | 164 | 2012 |
| Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes A Osman, K Fälker Platelets 22 (6), 433-441, 2011 | 133 | 2011 |
| Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records A Osman, C Enström, K Arbring, P Söderkvist, TL Lindahl Journal of Thrombosis and Haemostasis 4 (8), 1723-1729, 2006 | 77 | 2006 |
| Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function A Osman, WE Hitzler, CU Meyer, P Landry, A Corduan, B Laffont, ... Platelets 26 (2), 154-163, 2015 | 75 | 2015 |
| Influence of UGT2B7, OPRM1 and ABCB1 Gene Polymorphisms on Postoperative Morphine Consumption S Bastami, A Gupta, AL Zackrisson, J Ahlner, A Osman, S Uppugunduri Basic & clinical pharmacology & toxicology 115 (5), 423-431, 2014 | 74 | 2014 |
| A new high-performance liquid chromatographic method for determination of warfarin enantiomers A Osman, K Arbring, TL Lindahl Journal of Chromatography B 826 (1-2), 75-80, 2005 | 68 | 2005 |
| Next generation sequencing analysis of human platelet PolyA+ mRNAs and rRNA-depleted total RNA A Kissopoulou, J Jonasson, TL Lindahl, A Osman PloS one 8 (12), e81809, 2013 | 60 | 2013 |
| Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems A Osman, WE Hitzler, A Ameur, P Provost PLoS One 10 (7), e0133070, 2015 | 46 | 2015 |
| miR‐20b regulates expression of proteinase‐activated receptor‐1 (PAR‐1) thrombin receptor in melanoma cells A Saleiban, L Faxälv, K Claesson, JI Jönsson, A Osman Pigment cell & melanoma research 27 (3), 431-441, 2014 | 39 | 2014 |
| The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets M Nylander, A Osman, S Ramström, E Åklint, A Larsson, TL Lindahl Thrombosis research 129 (4), e51-e58, 2012 | 27 | 2012 |
| The platelets’ perspective to pathogen reduction technologies A Osman, WE Hitzler, P Provost Platelets 29 (2), 140-147, 2018 | 16 | 2018 |
| Effects of metal ions on the substrate-specificity and activity of proton-pumping nicotinamide nucleotide transhydrogenase from Escherichia coli J Zhang, X Hu, AM Osman, J Rydström Biochimica et Biophysica Acta (BBA)-Bioenergetics 1319 (2-3), 331-339, 1997 | 16 | 1997 |
| Platelet pathogen reduction technologies alter the microRNA profile of platelet-derived microparticles I Diallo, A Benmoussa, J Laugier, A Osman, WE Hitzler, P Provost Frontiers in Cardiovascular Medicine 7, 31, 2020 | 15 | 2020 |
| Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma–The predictive significance of B blood group MK Heenkenda, A Malmström, M Lysiak, M Mudaisi, C Bratthäll, P Milos, ... Thrombosis research 183, 136-142, 2019 | 15 | 2019 |
| Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V AA Abdi, A Osman Journal of Thrombosis and Thrombolysis 44, 536-543, 2017 | 15 | 2017 |
| Genome-wide analyses disclose the distinctive HLA architecture and the pharmacogenetic landscape of the Somali population AA Ali, M Aalto, J Jonasson, A Osman Scientific reports 10 (1), 1-11, 2020 | 10 | 2020 |
| Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations MK Heenkenda, TL Lindahl, A Osman Blood, The Journal of the American Society of Hematology 132 (19), 2103-2106, 2018 | 10 | 2018 |
| Peculiarities of studying the effects of pathogen reduction technologies on platelets A Osman, WE Hitzler, P Provost PROTEOMICS–Clinical Applications 10 (8), 805-815, 2016 | 9 | 2016 |
| A genotyping method for VKORC1 1173C>T by Pyrosequencing® technology C Enström, A Osman, TL Lindahl Scandinavian Journal of Clinical and Laboratory Investigation 68 (5), 427-430, 2008 | 9 | 2008 |
| Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype A Osman, C Enström, TL Lindahl Blood coagulation & fibrinolysis 18 (3), 293-296, 2007 | 9 | 2007 |
Patrick ProvostFull Professor, Université LavalAdresse e-mail validée de crchudequebec.ulaval.ca
